This report provides in-depth qualitative and overall analysis of the” Radiotherapy Market” on a regional level from 2018 to 2023. The study also provides a comprehensive review of restraints, Market Dynamics, drivers and opportunities along with their impact on the overall market. The report segments the Industry and Key developments and strategies for key players.

Pune, India -- (SBWire) -- 05/16/2018 --Global Radiotherapy Market - Overview

The market for Radiotherapy will grow very rapidly at a rate of 7% CAGR during the forecasted period 2017-2023. The market is expected to reach USD 7 million from 4.5 million in 2016 during the forecasted period.

Radiotherapy is used for the treatment of various types of cancer. The therapy uses high power X-rays to destroy cancerous cells. According to the National Cancer Institute, about 50% of cancer patients receive some type of radiation therapy during their treatment. The radiotherapy treatment are less painful than the chemotherapy and surgeries. The damaged cells are broken down by the natural process of body.

To get sample copy of Report Click Here @ https://www.marketresearchfuture.com/sample_request/1526 .

The cancerous cells get destroyed totally and does not show its presence in future. The time required is much less in contrast to the chemotherapy. The side effects of the radiotherapy is also nominal as compared to the chemotherapy. Around 4 out of every 10 people are treated for cancer undergo radiotherapy. Normally together with other types of treatment including chemotherapy and surgery. The market for the radiotherapy is increasing as the treatment is quick and easy. The treatment is more effective than chemotherapy and surgery. Though treatment has some side effects but the therapy is widely preferred by doctors.

GE Healthcare (UK), Siemens (Germany), Cardinal Health (U.S.), Nordion (CA), View ray (U.S.), Fuji Holdings (Japan), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Hologic (U.S.), Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), Mitsubishi Electric Corporation (Japan), CIVCO Medical Solutions (U.S.), Brainlab AG (Germany), PRECISIS AG (Germany), Technicas Radiofiscas S.L (Spain), Hitachi Ltd. (Japan), Sumitomo Heavy Industries Ltd. (Japan), ProNova Solutions LLC (U.S.), ProTom International (U.S.), and others are some of the prominent players at the forefront of competition in the global radiotherapy market and are profiled in MRFR Analysis.

Key Participants:

Some of the players are involved in manufacturing of the Radiotherapy those are, GE Healthcare(UK), Siemens (Germany), Varian(India), Cardinal Health(US), Nordion(CA), Isoray(US), View ray (US), Fuji Holdings(Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), Hologic (US).

Segmentation:

The segmentation for the radiotherapy market is done on the basis of the treatment type and by application. On the basis of treatment type includes X-Ray, Gamma ray, External Beam radiotherapy, proton therapy, internal radiation therapy. The external beam radiotherapy segment is further sub-segmented into the treatment types which are 3D conformal radiation therapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Tomotherapy, Stereotactic radio surgery, and stereotactic body radiation therapy. On the basis of the application the segment are prostate cancer, breast cancer and lung cancer, ovarian cancer and thyroid.

Regional Analysis:
The radiotherapy market is segmented into four main geographic regions Americas, Europe, Asia-Pacific, and Middle East and Africa. America holds the larger market in the radiotherapy the market increasing due to the increasing advancement in the technology. Europe is another dominating region for the use of the radiotherapy. Asia-pacific region is growing at a rapid pace because of the increasing number of patients in the region. The number is increasing due to the more consumptions of tobacco is seen in this region. Middle East and Africa is slow growing segment because of the lack of awareness of the chronic diseases and the treatment facilities are also limited in this region.

Get Marvelous Discount @ https://www.marketresearchfuture.com/check-discount/1526 .

Industry Updates:

Jan, 2018 Varian Medical Systems signed an agreement to acquire Sirtex Medical Limited. This acquisition expands Varian's addressable market into interventional oncology to emerge as a global leader in radio embolization.

October, 2017 Varian has launched its radiotherapy device ProBeam Compact single-room proton therapy system.

July, 2017 View Ray has recently announced the launch of MRI-guided radiation therapy solution, MRIdian Linac.

TOC of Radiotherapy Market:

TABLE OF CONTENTS

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL RADIOTHERAPY MARKET MARKET, BY TYPE

CONTINUED TOC…

Key Questions Answered In This Report:

What will the market size and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

All the queries about this report can be asked @ https://www.marketresearchfuture.com/enquiry/1526 .

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com